Clinical Trials Browser

Approved for marketing × carfilzomib × Clear all

NCT01410500 2017-05-02

Carfilzomib Multiple Myeloma Expanded Access Protocol for Patients With Relapsed and Refractory Disease

Approved for marketing

Multiple Myeloma